Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/1999
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948356A1 Agent for identifying and treating metastasizing tumours
10/13/1999EP0948353A1 Methods and compositions for immunomodulation
10/13/1999EP0948345A1 Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
10/13/1999EP0948334A1 Method of treating prostatic diseases using active vitamin d analogues
10/13/1999EP0948324A2 Methods and pharmaceutical compositions for inhibiting tumour cell growth
10/13/1999EP0936912A4 Inhibitors of cysteine protease
10/13/1999EP0850300B1 Method of modulating gene expression with reduced immunostimulatory response
10/13/1999EP0817780B1 Novel taxoids, preparation thereof and pharmaceutical compositions containing same
10/13/1999EP0668854B1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress
10/13/1999CN1231694A Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase
10/13/1999CN1231672A Conformationally constrained backbone cyclized somatostatin analogs
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
10/13/1999CN1231131A Insects protein capsule or powder medicine and preparation process thereof
10/13/1999CN1045621C Process for preparing immunoglobulin conjugates
10/12/1999US5965763 Biphenyl compounds
10/12/1999US5965722 Oligonucleotide with methylene(methylimino) linkages alternating with phosphorothioate or phosphodiester linkages; with increased nuclease resistance, stability, affinity for messenger rna; anticarcinogenic/antiarrhythmia agents
10/12/1999US5965720 With sequence complementary to messenger rna from a gene selected from the group consisting of c-myc, c-myb, c-fos, c-kit, ras and bcr/abl; antisense/anticarcinogenic agents
10/12/1999US5965718 Analogs of sarcodictyin and eleutherobin
10/12/1999US5965711 A protein; anticarcinogenic/antiarthritic/antidiabetic agents; treatment of addison's and crohn's disease, multiple sclerosis, scleroderma, ulcers, respiratory disorders; fungicides, viricides, bactericides
10/12/1999US5965710 An immunoglobulin which binds human membrane-bound carcinoembryonic antigen; anticarcinogenic agent
10/12/1999US5965609 An antitumor agent, antimalaria agent, bactericide treating gram-negative bacteria and active drug treating stroke, traumatic brain injury, chronic neurodegenerative disease, alzheimer's disease or amyotropic lateral schlerosis
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965604 Antibacterial and antitumor activities; produced by culturing streptomyces an recovering compound
10/12/1999US5965579 Antagonists of the neurotensin receptors; increasing affinity for human neurotensin receptors
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965563 Aryl and heteroaryl purine compounds
10/12/1999US5965537 Anticancer agents; water solubility
10/12/1999US5965535 Isolated human leukocyte antigen (hla) class ii-binding peptide and amino sequence encoding it; the peptides stimulate the activity and proliferation of cd4+ t lymphocytes
10/12/1999US5965532 Low molecular weight, synthetic crosslinking boron compounds as an agonists or antagonists and induce association between naturally occurring receptors, t cell surface receptor
10/12/1999US5965523 Promoting angiogenesis by administering scatter factor
10/12/1999US5965493 Therapeutic Quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
10/12/1999US5965430 Bioactive substance having antitumor activity, producing strain, and production thereof
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965407 Anthracycline compound 0624
10/12/1999US5965404 Adding nucleic acid/polycation complexes to animal cells in presence of ethylene glycol and/or glycerol; for simple and accurate transfection of cells for gene therapy and tumor vaccine production
10/12/1999US5965397 Protein factor, cytokines, lymphokines, interferons, and interleukins, and colony stimulating factors; treatment of osteoporosis, stimulating or bone growth, regeneration of nerve and brain tissue, alzheimer/huntington disease's
10/12/1999US5965396 Human lymph node derived GTPase
10/12/1999US5965388 Isolated polynucleotides; diagnosis and treatment autoimmune diseases, tissue rejection, allergies, acquired immune deficiency disease; viricides, bactericides and fungicides; anticarcinogenic agents
10/12/1999US5965382 Nucleic acid encoding secreted Mac-2 binding glycoprotein
10/12/1999US5965381 A mutant strain deficient in producing functional effector proteins; used for heterologous protein transfer into antigen presenting cells; treating infections by pathogens; inducing cellular immune response
10/12/1999US5965373 Identifying enzyme inhibitors by combining a dimeric protein with a substrate, and a compound believed to be an inhibitor and determining activity of the protein on the substrate; diagnosis of epithelial cancer
10/12/1999US5965360 Diagnosis of metastatic cancer by the mts-1 gene
10/12/1999US5965133 Self-assembling multimeric nucleic acid constructs
10/12/1999US5965132 Methods and compositions for targeting the vasculature of solid tumors
10/12/1999US5965130 Inhibiting metastasis of a tumor in a mammal by administering intravenous immunoglobulin (inig) in a specific dosage either as a sole agent or in combination with other agent used in cancer treatment
10/12/1999US5965129 Purified cathepsin polypeptide and amino acid sequence or immunologically active fragments thereof; administering the novel protein with a pharmaceutical carrier to treat cancer
10/12/1999US5965126 use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
10/12/1999US5965118 Polymer-platinum compounds
10/12/1999US5965108 Cyclic peptide-metal complex specifically binds to surface somatostatin receptor-expressing cells; radiology; scintigraphy; antitumor,-carcinogenic and metastatic agents; stability
10/12/1999CA1340784C 7-(2-methyl-4-aminopyrrolidinyl)naphthyridine and quinoline compounds
10/12/1999CA1340781C Tumor specific monoclonal antibodies
10/07/1999WO1999050658A2 Methods and compounds for modulating nuclear receptor activity
10/07/1999WO1999050461A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY
10/07/1999WO1999050403A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses
10/07/1999WO1999050396A1 Nek1-related protein kinase
10/07/1999WO1999050392A1 Methods and compositions for eliciting an immune response to a telomerase antigen
10/07/1999WO1999050391A1 Stimulated monocyte derived cells, their preparation and uses
10/07/1999WO1999050297A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof
10/07/1999WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999WO1999050275A2 Macrolide lhrh antagonists
10/07/1999WO1999050272A1 Phosphinic acid derivatives
10/07/1999WO1999050269A2 Porphyrins and their use as photosensitizer
10/07/1999WO1999050265A1 Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents
10/07/1999WO1999050251A2 Cyclin dependent kinase inhibitors
10/07/1999WO1999050249A2 Pyrimidines and triazines as integrin antagonists
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049881A2 Application of hsp70 proteins
10/07/1999WO1999049871A1 Method of inhibiting membrane-type matrix metalloproteinase
10/07/1999WO1999049870A1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
10/07/1999WO1999049869A1 Methods to potentiate intravenous estramustine phosphate
10/07/1999WO1999049859A1 Dfmo and sulindac combination in cancer chemoprevention
10/07/1999WO1999049848A1 Anticancer compositions
10/07/1999WO1999049774A2 Methods for the diagnosis and treatment of lung cancer
10/07/1999WO1999049735A1 Mpr-related abc transporter encoding nucleic acids and methods of use thereof
10/07/1999WO1999043310A3 20-hete antagonists and agonists
10/07/1999WO1999040220A3 Method of screening therapeutic agents
10/07/1999WO1999032509A3 Hemiasterlin analogs
10/07/1999WO1999031128A3 Human tumor necrosis factor-r2-like proteins
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/07/1999DE19816395A1 Menschliche Nukleinsäuresequenzen aus Ovar-Normalgewebe Nucleic acid sequences from human ovarian normal tissue
10/07/1999DE19814405A1 Neue Porphyrine und ihre Verwendung New porphyrins and their use
10/07/1999DE19813760A1 Activation of natural killer cells to stimulate immune response, especially in treatment of tumors, infections and autoimmune diseases
10/07/1999DE19812941A1 Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor Medicines used to prevent or treat Papillomavirusspezifischem tumor
10/07/1999DE19812940A1 Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung Formulation with papillomavirus-specific protein, its preparation and use
10/07/1999CA2735260A1 Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression
10/07/1999CA2731416A1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
10/07/1999CA2401916A1 Recombinant anti-tumor rnase
10/07/1999CA2347067A1 Dendritic cell vaccine containing telomerase reverse transcriptase for the treatment of cancer
10/07/1999CA2333927A1 Pyrimidines and triazines as integrin antagonists
10/07/1999CA2326357A1 Cyclin dependent kinase inhibitors
10/07/1999CA2326117A1 Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
10/07/1999CA2325735A1 Hsp70 protein for the treatment of tumours, cancer or infectious diseases through nk-cell activation
10/07/1999CA2325521A1 Macrolide lhrh antagonists
10/07/1999CA2325080A1 Dfmo and sulindac combination in cancer chemoprevention
10/07/1999CA2324864A1 Immune response modulator alpha-2 macroglobulin complex
10/07/1999CA2324652A1 Nek1-related protein kinase
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
1 ... 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 ... 2211